(RTTNews) - Late-stage clinical biopharma company Acelyrin, Inc. (SLRN) Monday said that there was a programming error in its drug trial of a treatment for psoriatic ...
The medical scheduling site Zocdoc published a letter this week describing a programming error that allowed patient information to be exposed to providers in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results